Clinical Trials in Los Angeles

Showing 5961-5980 of 12,794 trials

COMPLETEDPhase 4< 1 mile

Assessment of Atrophogenic Potential of Triple Combination Cream for Treatment of Melasma

NCT00469183

Evaluate atrophogenic potential of long-term use of Tri-Luma Cream on facial Melasma through biopsy examination.

Melasma

Galderma R&D70 participantsStarted May 2006

Los Angeles, California, United States • Dallas, Texas, United States

COMPLETED< 1 mile

A Clinical Assessment Study in X-Linked Myotubular Myopathy (XLMTM) Subjects

NCT02704273

This is a pre-Phase 1 prospective, non interventional clinical assessment study to evaluate XLMTM subjects aged 3 years and younger. Many of these clinically relevant measures have not yet been routinely assessed in this population and may provide important insight on the natural history of XLMTM and for future evaluation of potential therapies.

X-linked Myotubular Myopathy

Astellas Gene Therapies34 participantsStarted Jul 2016

Los Angeles, California, United States • Gainesville, Florida, United States • Chicago, Illinois, United States +5 more locations

COMPLETEDPhase 1< 1 mile

A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer

NCT02684032

This is a multicenter, open label, Phase 1b study in patients with mBC. This study will have a dose escalation to identify the maximum tolerated dose (MTD) of the combination of gedatolisib plus palbociclib/fulvestrant and gedatolisib plus palbociclib/letrozole and expansion to estimate the objective response rate (OR) of the combination of gedatolisib plus palbociclib/letrozole or palbociclib/fulvestrant.

Breast Cancer

Celcuity Inc141 participantsStarted Jun 2016

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Corona, California, United States +38 more locations

Assessment of Atrophogenic Potential of Triple Combination Cream for Treatment of Melasma

A Clinical Assessment Study in X-Linked Myotubular Myopathy (XLMTM) Subjects

A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer

Find Trials by Condition in Los Angeles

Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis

Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients Who Have an Inadequate Response to Eculizumab

Cefixime for Alternative Syphilis Treatment

Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast Tissue

A Study to Evaluate the Effect of Lycomato on Skin Attributes in Healthy Participants.

Reactive vs. Proactive Pain Control in IBD

Safety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants With Human Immunodeficiency Virus (HIV) and Hyperlipidemia/Mixed Dyslipidemia

Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis

Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms

Study of the Safety, Efficacy and PK of EYN-1601 in Dilation of the Pupil

Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma

A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1

Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne

A Study of FOR46 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)

Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy

A Study of Immune Responses to the Virus That Causes COVID-19

A Study Evaluating Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Subjects 6 Through 11 Years of Age With Cystic Fibrosis and F/MF Genotypes